| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 18 | 2024 | 90 | 5.280 |
Why?
|
| Joint Instability | 11 | 2023 | 81 | 4.100 |
Why?
|
| Patellofemoral Joint | 9 | 2023 | 16 | 3.600 |
Why?
|
| Anterior Cruciate Ligament | 13 | 2021 | 48 | 3.180 |
Why?
|
| Knee Joint | 15 | 2023 | 168 | 3.100 |
Why?
|
| Orthopedic Procedures | 9 | 2023 | 128 | 2.560 |
Why?
|
| Rotator Cuff Injuries | 11 | 2022 | 46 | 2.260 |
Why?
|
| Arthroscopy | 12 | 2021 | 94 | 2.110 |
Why?
|
| Shoulder | 10 | 2022 | 42 | 2.050 |
Why?
|
| Knee Injuries | 10 | 2024 | 53 | 2.020 |
Why?
|
| Surgery, Computer-Assisted | 6 | 2014 | 99 | 1.870 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 6 | 2023 | 25 | 1.770 |
Why?
|
| Cartilage, Articular | 7 | 2023 | 67 | 1.740 |
Why?
|
| Patellar Dislocation | 4 | 2023 | 11 | 1.690 |
Why?
|
| Orthopedics | 5 | 2023 | 124 | 1.690 |
Why?
|
| Joint Diseases | 4 | 2020 | 49 | 1.560 |
Why?
|
| Tibia | 8 | 2022 | 82 | 1.490 |
Why?
|
| Femur | 6 | 2021 | 116 | 1.480 |
Why?
|
| Tibial Meniscus Injuries | 3 | 2022 | 19 | 1.460 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 3 | 2021 | 18 | 1.410 |
Why?
|
| Menisci, Tibial | 4 | 2022 | 25 | 1.400 |
Why?
|
| Elbow Joint | 4 | 2022 | 34 | 1.350 |
Why?
|
| Patella | 9 | 2024 | 32 | 1.240 |
Why?
|
| Patient Positioning | 3 | 2019 | 63 | 1.210 |
Why?
|
| Biomechanical Phenomena | 24 | 2024 | 457 | 1.200 |
Why?
|
| Anesthetics, Local | 2 | 2023 | 76 | 1.070 |
Why?
|
| Chondrocytes | 5 | 2015 | 60 | 1.070 |
Why?
|
| Range of Motion, Articular | 15 | 2024 | 154 | 1.060 |
Why?
|
| Shoulder Dislocation | 2 | 2022 | 16 | 1.050 |
Why?
|
| Endrin | 1 | 2023 | 2 | 0.960 |
Why?
|
| Orthopedic Surgeons | 1 | 2024 | 17 | 0.950 |
Why?
|
| Athletic Injuries | 4 | 2012 | 91 | 0.930 |
Why?
|
| Sports Medicine | 3 | 2008 | 56 | 0.920 |
Why?
|
| Tendon Injuries | 5 | 2022 | 37 | 0.910 |
Why?
|
| Humans | 88 | 2024 | 86643 | 0.900 |
Why?
|
| Rotator Cuff | 8 | 2021 | 44 | 0.880 |
Why?
|
| Osteoarthritis | 5 | 2015 | 73 | 0.870 |
Why?
|
| Arthritis | 1 | 2022 | 46 | 0.820 |
Why?
|
| Weight-Bearing | 5 | 2017 | 61 | 0.730 |
Why?
|
| Surgeons | 1 | 2024 | 238 | 0.700 |
Why?
|
| Arthroplasty, Replacement | 3 | 2015 | 37 | 0.680 |
Why?
|
| Osteotomy | 2 | 2017 | 31 | 0.680 |
Why?
|
| Meniscectomy | 1 | 2018 | 3 | 0.680 |
Why?
|
| Acetabulum | 2 | 2017 | 28 | 0.640 |
Why?
|
| Anterior Cruciate Ligament Injuries | 3 | 2015 | 40 | 0.630 |
Why?
|
| Cadaver | 11 | 2024 | 185 | 0.620 |
Why?
|
| Anesthesia, General | 3 | 2019 | 114 | 0.610 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2017 | 18 | 0.600 |
Why?
|
| Suture Anchors | 1 | 2017 | 5 | 0.600 |
Why?
|
| Debridement | 1 | 2017 | 56 | 0.600 |
Why?
|
| Postoperative Complications | 7 | 2021 | 2207 | 0.590 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 63 | 0.580 |
Why?
|
| Pressure | 6 | 2018 | 165 | 0.570 |
Why?
|
| Wound Healing | 3 | 2008 | 344 | 0.560 |
Why?
|
| Patellar Ligament | 2 | 2015 | 14 | 0.540 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2015 | 5 | 0.540 |
Why?
|
| Knee Dislocation | 1 | 2015 | 5 | 0.530 |
Why?
|
| Tissue Engineering | 4 | 2011 | 181 | 0.530 |
Why?
|
| Ulna | 2 | 2006 | 13 | 0.520 |
Why?
|
| Acromioclavicular Joint | 3 | 2024 | 5 | 0.510 |
Why?
|
| Arthroplasty, Replacement, Elbow | 1 | 2014 | 4 | 0.510 |
Why?
|
| Baseball | 2 | 2006 | 17 | 0.510 |
Why?
|
| Tendons | 2 | 2012 | 44 | 0.480 |
Why?
|
| Bone Wires | 2 | 2024 | 12 | 0.470 |
Why?
|
| Platelet-Rich Plasma | 1 | 2023 | 10 | 0.470 |
Why?
|
| Retrospective Studies | 16 | 2023 | 8489 | 0.460 |
Why?
|
| Anesthesia, Conduction | 1 | 2013 | 18 | 0.450 |
Why?
|
| Male | 39 | 2022 | 40965 | 0.440 |
Why?
|
| Awards and Prizes | 1 | 2013 | 36 | 0.440 |
Why?
|
| Hip | 1 | 2012 | 18 | 0.440 |
Why?
|
| Ankle Injuries | 3 | 2023 | 30 | 0.430 |
Why?
|
| Oximetry | 1 | 2013 | 84 | 0.430 |
Why?
|
| Arthralgia | 1 | 2012 | 36 | 0.430 |
Why?
|
| Citric Acid | 4 | 2018 | 38 | 0.430 |
Why?
|
| Hip Joint | 1 | 2012 | 55 | 0.420 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 41 | 0.420 |
Why?
|
| Running | 1 | 2012 | 25 | 0.420 |
Why?
|
| Medical History Taking | 1 | 2012 | 80 | 0.420 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 78 | 0.410 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 90 | 0.400 |
Why?
|
| Sutures | 1 | 2011 | 52 | 0.400 |
Why?
|
| Physical Examination | 1 | 2012 | 149 | 0.390 |
Why?
|
| Ligaments, Articular | 4 | 2023 | 36 | 0.380 |
Why?
|
| Joints | 3 | 2005 | 32 | 0.380 |
Why?
|
| Ankle Joint | 4 | 2023 | 46 | 0.370 |
Why?
|
| Middle Aged | 20 | 2022 | 25028 | 0.370 |
Why?
|
| Stress, Mechanical | 5 | 2017 | 248 | 0.360 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2009 | 23 | 0.350 |
Why?
|
| Treatment Outcome | 12 | 2022 | 7993 | 0.350 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2009 | 47 | 0.340 |
Why?
|
| Fractures, Bone | 2 | 2024 | 131 | 0.340 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2008 | 12 | 0.330 |
Why?
|
| Transplantation, Autologous | 2 | 2015 | 331 | 0.320 |
Why?
|
| Female | 29 | 2022 | 44532 | 0.320 |
Why?
|
| Biological Products | 2 | 2023 | 143 | 0.320 |
Why?
|
| United States | 7 | 2024 | 6672 | 0.310 |
Why?
|
| Adult | 21 | 2022 | 25648 | 0.310 |
Why?
|
| Aged | 18 | 2022 | 18415 | 0.310 |
Why?
|
| Humerus | 4 | 2024 | 31 | 0.310 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 184 | 0.310 |
Why?
|
| Prospective Studies | 6 | 2022 | 4213 | 0.310 |
Why?
|
| Muscle, Skeletal | 4 | 2016 | 449 | 0.300 |
Why?
|
| Medical Errors | 1 | 2008 | 115 | 0.300 |
Why?
|
| Bone Transplantation | 2 | 2004 | 64 | 0.300 |
Why?
|
| Pyomyositis | 1 | 2006 | 2 | 0.300 |
Why?
|
| Cartilage | 2 | 2004 | 113 | 0.300 |
Why?
|
| Collateral Ligaments | 1 | 2006 | 11 | 0.290 |
Why?
|
| Movement | 3 | 2020 | 299 | 0.280 |
Why?
|
| Absorbable Implants | 2 | 2006 | 34 | 0.280 |
Why?
|
| Biocompatible Materials | 6 | 2018 | 193 | 0.280 |
Why?
|
| Follow-Up Studies | 6 | 2022 | 3640 | 0.280 |
Why?
|
| Fractures, Stress | 2 | 2003 | 10 | 0.280 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2024 | 166 | 0.260 |
Why?
|
| Arthrodesis | 2 | 2014 | 26 | 0.250 |
Why?
|
| Arthroplasty, Replacement, Ankle | 2 | 2014 | 17 | 0.250 |
Why?
|
| Knee Prosthesis | 1 | 2004 | 33 | 0.250 |
Why?
|
| Prosthesis Failure | 1 | 2004 | 111 | 0.240 |
Why?
|
| Tissue Scaffolds | 2 | 2018 | 106 | 0.240 |
Why?
|
| Meniscus | 1 | 2023 | 1 | 0.240 |
Why?
|
| Stroke | 1 | 2013 | 965 | 0.240 |
Why?
|
| Bupivacaine | 1 | 2023 | 45 | 0.230 |
Why?
|
| Arthroplasty | 2 | 2020 | 27 | 0.230 |
Why?
|
| Diabetes Complications | 2 | 2014 | 207 | 0.220 |
Why?
|
| Rupture | 5 | 2022 | 63 | 0.220 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2004 | 111 | 0.220 |
Why?
|
| Electronic Mail | 1 | 2022 | 14 | 0.220 |
Why?
|
| Ontario | 1 | 2022 | 52 | 0.220 |
Why?
|
| Databases, Factual | 3 | 2014 | 814 | 0.220 |
Why?
|
| Propionibacteriaceae | 1 | 2022 | 1 | 0.210 |
Why?
|
| Regeneration | 2 | 2016 | 143 | 0.210 |
Why?
|
| Shoulder Fractures | 1 | 2021 | 11 | 0.200 |
Why?
|
| Prosthesis-Related Infections | 1 | 2022 | 58 | 0.200 |
Why?
|
| Stifle | 2 | 2011 | 2 | 0.200 |
Why?
|
| Length of Stay | 2 | 2014 | 702 | 0.200 |
Why?
|
| Nanocomposites | 2 | 2011 | 11 | 0.200 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 240 | 0.200 |
Why?
|
| Myocardial Ischemia | 1 | 2022 | 162 | 0.190 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 166 | 0.190 |
Why?
|
| Joint Capsule | 1 | 2020 | 6 | 0.190 |
Why?
|
| Shoulder Injuries | 1 | 2020 | 15 | 0.190 |
Why?
|
| Humeral Head | 1 | 2020 | 7 | 0.190 |
Why?
|
| Hospitalization | 3 | 2014 | 849 | 0.190 |
Why?
|
| Risk Factors | 5 | 2022 | 5417 | 0.190 |
Why?
|
| Coracoid Process | 1 | 2020 | 3 | 0.190 |
Why?
|
| Young Adult | 6 | 2022 | 5976 | 0.180 |
Why?
|
| Incidence | 4 | 2020 | 1577 | 0.180 |
Why?
|
| Tenodesis | 1 | 2020 | 6 | 0.180 |
Why?
|
| Bone Density | 1 | 2001 | 209 | 0.180 |
Why?
|
| Adolescent | 5 | 2022 | 8981 | 0.180 |
Why?
|
| Patellofemoral Pain Syndrome | 2 | 2009 | 3 | 0.180 |
Why?
|
| Quality Improvement | 1 | 2023 | 428 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2024 | 579 | 0.180 |
Why?
|
| Bone and Bones | 2 | 2011 | 265 | 0.180 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2001 | 102 | 0.170 |
Why?
|
| Isometric Contraction | 3 | 2004 | 38 | 0.170 |
Why?
|
| Tensile Strength | 3 | 2011 | 79 | 0.170 |
Why?
|
| Pain | 1 | 2022 | 391 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 413 | 0.170 |
Why?
|
| Delphi Technique | 3 | 2023 | 80 | 0.160 |
Why?
|
| Strontium | 1 | 2018 | 6 | 0.160 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 43 | 0.160 |
Why?
|
| Pain Measurement | 2 | 2012 | 321 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 350 | 0.150 |
Why?
|
| Phosphates | 1 | 2018 | 160 | 0.150 |
Why?
|
| Arthrography | 1 | 2016 | 6 | 0.150 |
Why?
|
| Femoracetabular Impingement | 1 | 2017 | 11 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 3362 | 0.150 |
Why?
|
| Models, Anatomic | 1 | 2016 | 91 | 0.140 |
Why?
|
| Osteogenesis | 1 | 2018 | 242 | 0.140 |
Why?
|
| Cartilage Diseases | 1 | 2015 | 16 | 0.140 |
Why?
|
| Cell Transplantation | 1 | 2015 | 47 | 0.140 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2501 | 0.140 |
Why?
|
| Reoperation | 3 | 2021 | 597 | 0.130 |
Why?
|
| Animals | 13 | 2023 | 26582 | 0.130 |
Why?
|
| Comorbidity | 2 | 2021 | 943 | 0.130 |
Why?
|
| Bone Screws | 2 | 2024 | 44 | 0.130 |
Why?
|
| Rabbits | 6 | 2014 | 636 | 0.130 |
Why?
|
| Recovery of Function | 4 | 2015 | 272 | 0.130 |
Why?
|
| Inpatients | 2 | 2014 | 297 | 0.130 |
Why?
|
| Patient Admission | 1 | 2014 | 112 | 0.120 |
Why?
|
| Cattle | 2 | 2011 | 376 | 0.120 |
Why?
|
| Spinal Fusion | 1 | 2014 | 85 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 148 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 6509 | 0.120 |
Why?
|
| Injections | 1 | 2023 | 109 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2014 | 185 | 0.120 |
Why?
|
| Swine | 2 | 2005 | 555 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 239 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2023 | 220 | 0.110 |
Why?
|
| Osteoarthritis, Hip | 2 | 2005 | 23 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2601 | 0.110 |
Why?
|
| Finite Element Analysis | 2 | 2024 | 74 | 0.110 |
Why?
|
| Shoes | 1 | 2012 | 5 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 109 | 0.110 |
Why?
|
| Allografts | 2 | 2023 | 172 | 0.110 |
Why?
|
| Radiography | 3 | 2014 | 813 | 0.100 |
Why?
|
| Child | 3 | 2023 | 6927 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 334 | 0.100 |
Why?
|
| Elasticity | 1 | 2011 | 94 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2705 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 2232 | 0.100 |
Why?
|
| Sex Distribution | 2 | 2014 | 173 | 0.090 |
Why?
|
| Age Distribution | 2 | 2014 | 204 | 0.090 |
Why?
|
| Braces | 1 | 2010 | 13 | 0.090 |
Why?
|
| Quadriceps Muscle | 1 | 2009 | 5 | 0.090 |
Why?
|
| Polymers | 2 | 2011 | 202 | 0.090 |
Why?
|
| Disinfection | 1 | 2009 | 14 | 0.090 |
Why?
|
| Bursa, Synovial | 1 | 2009 | 3 | 0.090 |
Why?
|
| Elbow | 1 | 2008 | 14 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 963 | 0.080 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2008 | 12 | 0.080 |
Why?
|
| Chondrogenesis | 1 | 2008 | 26 | 0.080 |
Why?
|
| Clavicle | 1 | 2007 | 11 | 0.080 |
Why?
|
| Probability | 2 | 2009 | 355 | 0.080 |
Why?
|
| Torque | 2 | 2004 | 10 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1565 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 123 | 0.080 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 53 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 114 | 0.080 |
Why?
|
| Spondylitis | 1 | 2006 | 2 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2014 | 2261 | 0.070 |
Why?
|
| Bone Substitutes | 1 | 2006 | 9 | 0.070 |
Why?
|
| Osteomyelitis | 1 | 2006 | 54 | 0.070 |
Why?
|
| Consensus | 2 | 2020 | 335 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 610 | 0.070 |
Why?
|
| Robotics | 1 | 2010 | 267 | 0.070 |
Why?
|
| Lactic Acid | 1 | 2006 | 90 | 0.070 |
Why?
|
| Decision Making | 1 | 2022 | 642 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 301 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2008 | 342 | 0.070 |
Why?
|
| Durapatite | 3 | 2011 | 28 | 0.070 |
Why?
|
| Materials Testing | 3 | 2011 | 91 | 0.070 |
Why?
|
| Exercise | 1 | 2008 | 315 | 0.070 |
Why?
|
| Toe Joint | 1 | 2005 | 1 | 0.070 |
Why?
|
| Hip Injuries | 1 | 2005 | 1 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2014 | 1004 | 0.070 |
Why?
|
| Foot Joints | 1 | 2005 | 4 | 0.070 |
Why?
|
| Wrist Joint | 1 | 2005 | 23 | 0.060 |
Why?
|
| Wrist Injuries | 1 | 2005 | 14 | 0.060 |
Why?
|
| Perioperative Period | 2 | 2014 | 25 | 0.060 |
Why?
|
| Bone Malalignment | 1 | 2004 | 7 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2004 | 229 | 0.060 |
Why?
|
| Acromion | 1 | 2024 | 3 | 0.060 |
Why?
|
| Scapula | 1 | 2024 | 23 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 255 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2018 | 420 | 0.060 |
Why?
|
| Porosity | 2 | 2014 | 60 | 0.060 |
Why?
|
| Fracture Fixation, Internal | 1 | 2024 | 66 | 0.060 |
Why?
|
| Illinois | 1 | 2004 | 462 | 0.060 |
Why?
|
| Synovial Cyst | 1 | 2003 | 8 | 0.060 |
Why?
|
| Metatarsal Bones | 1 | 2003 | 6 | 0.060 |
Why?
|
| Autografts | 1 | 2022 | 28 | 0.060 |
Why?
|
| Foot | 1 | 2003 | 50 | 0.060 |
Why?
|
| Extremities | 1 | 2004 | 167 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2004 | 678 | 0.050 |
Why?
|
| Brain | 1 | 2013 | 2216 | 0.050 |
Why?
|
| Rotation | 3 | 2009 | 89 | 0.050 |
Why?
|
| Football | 1 | 2003 | 43 | 0.050 |
Why?
|
| Propionibacterium acnes | 1 | 2022 | 6 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 2767 | 0.050 |
Why?
|
| Sheep | 1 | 2002 | 239 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1458 | 0.050 |
Why?
|
| Polyesters | 2 | 2014 | 41 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 135 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2001 | 24 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2023 | 996 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 2001 | 34 | 0.050 |
Why?
|
| Registries | 1 | 2004 | 702 | 0.050 |
Why?
|
| Arm | 1 | 2021 | 91 | 0.050 |
Why?
|
| Tendon Transfer | 1 | 2020 | 5 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2020 | 27 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2020 | 84 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2018 | 52 | 0.040 |
Why?
|
| Antioxidants | 1 | 2018 | 223 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 396 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2009 | 347 | 0.040 |
Why?
|
| China | 1 | 2016 | 228 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 240 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 116 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 78 | 0.030 |
Why?
|
| Stem Cells | 1 | 2018 | 351 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 62 | 0.030 |
Why?
|
| Operative Time | 1 | 2015 | 127 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 729 | 0.030 |
Why?
|
| Phenylephrine | 1 | 2014 | 35 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 90 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 60 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2014 | 34 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 53 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 364 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 407 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 188 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2468 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2014 | 238 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1805 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2818 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 5210 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2011 | 24 | 0.030 |
Why?
|
| Citrates | 1 | 2011 | 28 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 770 | 0.030 |
Why?
|
| Viscosity | 1 | 2011 | 46 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 1204 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1578 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 135 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 999 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 884 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 132 | 0.030 |
Why?
|
| Heart Rate | 1 | 2014 | 492 | 0.030 |
Why?
|
| Particle Size | 1 | 2011 | 122 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2010 | 16 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 710 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2011 | 157 | 0.020 |
Why?
|
| Sprains and Strains | 1 | 2009 | 12 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 912 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2014 | 751 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1801 | 0.020 |
Why?
|
| Hypoxia | 1 | 2014 | 641 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1143 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 758 | 0.020 |
Why?
|
| Compliance | 1 | 2007 | 23 | 0.020 |
Why?
|
| Goats | 1 | 2006 | 18 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2006 | 33 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2006 | 95 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2008 | 839 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1991 | 0.020 |
Why?
|
| Electromyography | 1 | 2004 | 183 | 0.020 |
Why?
|
| Action Potentials | 1 | 2004 | 573 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 306 | 0.010 |
Why?
|